References
- ATHENA Network. DREAMS. Young women LEARN project year 1. review. http://www.athenanetwork.org/assets/files/LEARN/ATHENA%20Initiative_LEARN%20Year%201%20Review.pdf
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/NEJMoa1108524
- Celum, C. L., Delany-Moretlwe, S., Baeten, J. M., Straten, A., Hosek, S., Bukusi, E. A., McConnell, M., Barnabas, R. V., & Bekker, L. (2019). HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. Journal of the International AIDS Society, 22(S4), e25298. https://doi.org/10.1002/jia2.25298
- Celum, C. L., Delany-Moretlwe, S., McConnell, M., Van Rooyen, H., Bekker, L.-G., Kurth, A., Bukusi, E., Desmond, C., Morton, J., & Baeten, J. M. (2015). Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. Journal of the International AIDS Society, 18(Suppl. 3), 20227. https://doi.org/10.7448/IAS.18.4.20227
- Celum, C. L., Mgodi, N., Bekker, L.-G., Hosek, S., Donnell, D., Anderson, P., Dye, B. J., Pathak, S., Agyei, Y., Fogel, J. M., Marzinke, M. A., & Delany-Moretlwe, S. (2019). PrEP adherence and effect of drug level feedback among young African women in HPTN 082. 10th IAS Conference on HIV Science, Mexico City, Mexico, July 21-24.
- Chang, L. W., Serwadda, D., Quinn, T. C., Wawer, M. J., Gray, R. H., & Reynolds, S. J. (2013). Combination implementation for HIV prevention: Moving from evidence to population-level impact. Lancet Infectious Diseases, 13(1), 65–76. https://doi.org/10.1016/S1473-3099(12)70273-6
- Chen, L., Jha, P., Stirling, B., Sgaier, S. K., Daid, T., Kaul, R., Nagelkerke, N., & Nandi, S. (2007). Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: Systematic overview of 68 epidemiological studies. PLoS One, 2(10), e1001. https://doi.org/10.1371/journal.pone.0001001
- Chimbindi, N., Birdthistle, I., Shahmanesh, M., Osindo, P. M., Mushati, P., Ondeng’e, K., Zuma, T., Chiyaka, T., Kyegombe, N., Hargreaves, J., Busza, J., Floyd, S., Seeley, J., & Carael, M. (2018). Translating DREAMS into practice: Early lessons from implementation in six settings. PLoS One, 13(12), e0208243. https://doi.org/10.1371/journal.pone.0208243
- Dellar, R. C., Dlamini, S., & Abdool Karim, Q. (2015). Adolescent girls and young women: Key population for HIV epidemic control. Journal of the International AIDS Society, 18(Suppl. 1), 19408. https://doi.org/10.7448/IAS.18.2.19408
- Glynn, J. R., Caraël, M., Auvert, B., Kahindo, M., Chege, J., Musonda, R., Kaona, F., & Buvé, A. (2001). Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. Aids (london, England), 15(Suppl. 4), S51–S60. https://doi.org/10.1097/00002030-200108004-00006
- Govender, K., Masebo, W., Nyamaruze, P., Cowden, R. G., Schunter, B. T., & Bains, A. (2018). HIV prevention in adolescents and young people in Eastern Africa region: A review of key challenges impeding actions for an effective response. The Open AIDS Journal, 12(1), 53–67. https://doi.org/10.2174/1874613601812010053
- Grant, R. M. L., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernández, T., Veloso, V. G., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Mayer, K. H., Kallás, E. G., … Glidden, D. V. (2010). Preexposure Chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587–2599. https://doi.org/10.1056/NEJMoa1011205
- Hanscom, B., Janes, H. E., Guarino, P. D., Huang, Y., Brown, E. R., Chen, Y. Q., Hammer, S. M., Gilbert, P. B., & Donnell, D. J. (2016). Preventing HIV-1 infection in women using oral pre-exposure prophylaxis: A meta-analysis of current evidence. Journal of Acquired Immune Deficiency Syndrome, 73(5), 606–608. https://doi.org/10.1097/QAI.0000000000001160
- Hensen, B., Hargreaves, J. R., Chiyaka, T., Chabata, S., Mushati, P., Floyd, S., Birdthistle, I., Busza, J., & Cowan, F. (2018). Evaluating the impact of DREAMS on HIV incidence among young women who sell sex: Protocol for a non-randomized study in Zimbabwe. BMC Public Health, 18(1), 203. https://doi.org/10.1186/s12889-018-5085-6
- Huang, Y. L. A., Tao, G., Smith, D. K., & Hoover, K. W. (2020). Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012–2017. Clinical Infectious Diseases, https://doi.org/ 10.1093/cid/ciaa037
- Idele, P., Gillespie, A., Porth, T., Suzuki, C., Mahy, M., Kasedde, S., & Luo, C. (2014). Epidemiology of HIV and AIDS among adolescents: Current status, inequities, and data gaps. Journal of Acquired Immune Deficiency Syndromes, 66(Suppl. 2), S144–S153. https://doi.org/10.1097/QAI.0000000000000176
- Jewkes, R. K., Dunkle, K., Nduna, M., & Shai, N. (2010). Intimate partner violence, relationship power inequality, and incidence of HIV infection in young women in South Africa: A cohort study. The Lancet, 376(9734), 41–48. https://doi.org/10.1016/S0140-6736(10)60548-X
- Kenya Ministry of Health. (2016). Guidelines on the use of antiretroviral drugs for treating and preventing HIV in Kenya (2016 Edition). https://www.prepwatch.org/wp-content/uploads/2016/08/Guidelines-on-ARV-for-Treating-Preventing-HIV-Infections-in-Kenya.pdf.
- Kenya Ministry of Health. (2018a). Guidelines on the use of antiretroviral drugs for treating and preventing HIV in Kenya (2018 Edition). http://cquin.icap.columbia.edu/wp-content/uploads/2017/04/ICAP_CQUIN_Kenya-ARV-Guidelines-2018-Final_20thAug2018.pdf
- Kenya Ministry of Health. (2018b). Kenya HIV estimates report 2018. https://nacc.or.ke/wp-content/uploads/2018/11/HIV-estimates-report-Kenya-20182.pdf
- Kharsany, A. B. M., & Karim, Q. A. (2016). HIV infection and AIDS in sub-Sharan Africa: Current status, challenges and opportunities. The Open AIDS Journal, 10(1), 34–48. https://doi.org/10.2174/1874613601610010034
- Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, P. C., van Onzenoort, H. A., Leufkens, H. G., Bijlsma, J. W., & de Vries, F. (2015). Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporosis International, 26(6), 1831–1840. https://doi.org/10.1007/s00198-015-3084-3
- Kurth, A. E., Celum, C. L., Baeten, J. M., Vermund, S. H., & Wasserheit, J. N. (2011). Combination HIV prevention: Significance, challenges and opportunities. Current HIV/AIDS Reports, 8(1), 62–72. https://doi.org/10.1007/s11904-010-0063-3
- Kyongo, J. K., Kiragu, M., Karuga, R., Ochieng, C., Ngunjiri, A., Wachihi, C., Musyoki, H., Digolo, L., Otiso, L., Gelmon, L., & Kilonzo, N. (2018). How long will they take it? Oral pre-exposure prophylaxis (PrEP) retention for female sex workers, men who have sex with men and young women in a demonstration project in Kenya. 22nd International AIDS Conference , Amsterdam, the Netherlands, July 23-27.
- Louissaint, N. A., Cao, Y., Skipper, P. L., Liberman, R. G., Tannenbaum, S. R., Nimmagadda, S., Anderson, J. R., Everts, S., Bakshi, R., Fuchs, E. J., & Hendrix, C. W. (2013). Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue. AIDS Research Human Retroviruses, 29(11), 1443–1450. https://doi.org/10.1089/aid.2013.0044
- Masyuko, S., Mukui, I., Njathi, O., Kimani, M., Oluoch, P., Wamicwe, J., Mutegi, J., Njogo, S., Anyona, M., Muchiri, P., Maikweki, L., Musyoki, H., Bahati, P., Kyongo, J., Marwa, T., Irungu, E., Kiragu, M., Kioko, U., Ogando, J., … Cherutich, P. (2018). Pre-exposure prophylaxis rollout in a national public sector: The Kenyan case study. Sexual Health, 15(6), 578–586. https://doi.org/10.1071/SH18090
- Mathur, S., Pilgrim, N., & Pulerwitz, J. (2016). PrEP introduction for adolescent girls and young women. The Lancet HIV, 3(9), e406–e408. https://doi.org/10.1016/S2352-3018(16)30115-1
- Mugwanya, K., Pintye, J., Kinuthia, J., Abuna, F., Lagat, H., Begnel, E. R., Dettinger, J. C., John-Stewart, G., Baeten, J. M., & Geng, E. H. (2019). Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. PLoS Medicine, 16(9), e1002885. https://doi.org/10.1371/journal.pmed.1002885
- Nakku-Joloba, E., Pisarski, E. E., Wyatt, M. A., Muwonge, T. R., Asiimwe, S., Celum, C. L., Baeten, J. M., Katabira, E. T., & Ware, N. C. (2019). Beyond HIV prevention: Everyday life priority and demand for PrEP among Ugandan HIV serodiscordant couples. Journal of the International AIDS Society, 22(1), e25225. https://doi.org/10.1002/jia2.25225
- Nunn, A. S., Brinkley-Rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017). Defining the HIV pre-exposure prophylaxis care continuum. Aids (London, England), 31(5), 731–734. https://doi.org/10.1097/QAD.0000000000001385
- O’Malley, G., Barnabee, G., & Mugwanya, K. (2019). Scaling-up PrEP delivery in sub-Saharan Africa: What can we learn from the scale-up of ART? Current HIV/AIDS Reports, 16(2), 141–150. https://doi.org/10.1007/s11904-019-00437-6
- Patterson, K. B., Prince, H. A., Kraft, E., Jenkins, A. J., Shaheen, N. J., Rooney, J. F., Cohen, M. S., & Kashuba, A. D. (2011). Penetration of tenofovir and emtricitabine in mucosal tissues: Implications for prevention of HIV-1 transmission. Science Translational Medicine, 3(112), 112re4. https://doi.org/10.1126/scitranslmed.3003174
- PEPFAR. (2015). Preventing HIV in adolescent girls and young women. Guidance for PEPFAR country teams on the DREAMS partnership, 2015. http://ghpro.dexisonline.com/sites/default/files/2015-03-09%20%20FINAL%20DREAMS%20Guidance.pdf
- PEPFAR. (2016). Kenya country operational plan COP 2016 Strategic summary for the DREAMS Initiative. https://www.medbox.org/ke-policies-hiv-tb/kenya-country-operational-plan-cop-2016-strategic-direction-summary/preview?
- PEPFAR. (2018). DREAMS report 2018. https://www.pepfar.gov/documents/organization/287807.pdf
- Pettifor, A. E., Stoner, M., Pike, C., & Bekker, L.-G. (2018). Adolescent lives matter: Preventing HIV in adolescents. Current Opinion. HIV AIDS, 13(3), 265–273. https://doi.org/10.1097/COH.0000000000000453
- Pettifor, A. E., van der Straten, A., Dunbar, M. S., Shiboski, S. C., & Padian, N. S. (2004). Early age of first sex: A risk factor for HIV infection among women in Zimbabwe. Aids (London, England), 18(10), 1435–1442. https://doi.org/10.1097/01.aids.0000131338.61042.b8
- Price, J. T., Rosenberg, N. E., Vansia, D., Phanga, T., Bhushan, N. L., Maseko, B., Brar, S., Hosseinipour, M. C., Tang, J. H., Bekker, L. G., & Pettifor, A. (2018). Predictors of HIV, HIV risk perception, and HIV worry among adolescent girls and young women in Lilongwe, Malawi. Journal of Acquired Immune Deficiency Syndrome, 77(1), 53–63. https://doi.org/10.1097/QAI.0000000000001567
- Rousseau-Jemwa, E., Bekker, L.-G., Bukusi, E., Delaney-Moretlwe, S., Omollo, V., Travill, D., Morton, J., Kidoguchi, L., van der Straten, A., O’Malley, G., & Roberts, S. (2018). Early persistence of HIV Pre-exposure prophylaxis (PrEP) in African adolescent girls and young women (AGYW) from Kenya and South Africa. AIDS Research and Human Retroviruses, 34, 68. https://doi.org/10.1089/aid.2018.5000.abstracts.
- Saul, J., Bachman, G., Allen, S., Toiv, N. F., Cooney, C., & Beamon, T. (2018). The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women. PLos One, 18(12), e0208167. https://doi.org/10.1371/journal.pone.0208167.
- Sheth, A. N., Rolle, C. P., & Gandhi, M. (2016). HIV pre-exposure prophylaxis for women. Journal of Virus Eradication, 2, 149–155.
- Sia, D., Onadja, Y., Hajizadeh, M., Heymann, S. J., Brewer, T. F., & Nandi, A. (2016). What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys. BMC Public Health, 16(1), 1136. https://doi.org/10.1186/s12889-016-3783-5
- Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., … Brooks, J. T. (2012). Antiretroviral pre-exposure prophylaxis for heterosexual HIV transmission in Botswana. The New England Journal of Medicine, 367(5), 423–434. https://doi.org/10.1056/NEJMoa1110711
- UNAIDS. (2019). Women and HIV: a spotlight on adolescent girls and young women. https://www.unaids.org/sites/default/files/media_asset/2019_women-and-hiv_en.pdf
- USAID. (2019). The power of DREAMS. HIV prevention for AGYW in Western Kenya. 2019. https://path.azureedge.net/media/documents/DREAMS_Kenya_Overview_branded_FINAL.pdf
- Were, D., Musau, A., Mutegi, J., Ongwen, P., Manguro, G., Kamau, M., Marwa, T., Gwaro, H., Mukui, I., Plotkin, M., & Reed, J. (2020). Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: Results from a programmatic surveillance study. Journal of the International AIDS Society, 23(S3), e25537. https://doi.org/10.1002/jia2.25537.
- World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf